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Methicillin-resistant Staphylococcus aureus (MRSA) infections are a serious global
problem, with considerable impact on patients and substantial health care costs. This
systematic review provides an overview on the clonal diversity of MRSA, as well as the
prevalence of Panton-Valentine leukocidin (PVL)-positive MRSA in Africa. A search on
the molecular characterization of MRSA in Africa was conducted by two authors using
predefined terms. We screened for articles published in English and French through to
October 2014 from five electronic databases. A total of 57 eligible studies were identified.
Thirty-four reports from 15 countries provided adequate genotyping data. CC5 is the
predominant clonal complex in the healthcare setting in Africa. The hospital-associated
MRSA ST239/ST241-III [3A] was identified in nine African countries. This clone was also
described with SCCmec type IV [2B] in Algeria and Nigeria, and type V [5C] in Niger.
In Africa, the European ST80-IV [2B] clone was limited to Algeria, Egypt and Tunisia.
The clonal types ST22-IV [2B], ST36-II [2A], and ST612-IV [2B] were only reported in
South Africa. No clear distinctions were observed betweenMRSA responsible for hospital
and community infections. The community clones ST8-IV [2B] and ST88-IV [2B] were
reported both in the hospital and community settings in Angola, Cameroon, Gabon,
Ghana, Madagascar, Nigeria, and São Tomé and Príncipe. The proportion of PVL-positive
MRSA carriage and/or infections ranged from 0.3 to 100% in humans. A number of
pandemic clones were identified in Africa. Moreover, some MRSA clones are limited
to specific countries or regions. We strongly advocate for more surveillance studies on
MRSA in Africa.
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is a major public health concern and is respon-
sible for both hospital- and community-associated infections worldwide (De Kraker et al., 2011;
CDC, 2013; Falagas et al., 2013; Garza-González and Dowzicky, 2013; Lee et al., 2013; Chen and
Huang, 2014). It is estimated that MRSA infections within the health care setting alone aﬀected
more than 150,000 patients annually in the European Union, with an additional cost of 380 million
Euros (Köck et al., 2010). In the United States of America, 80,461 invasive MRSA infections and
11,285 related deaths occurred in 2011, and an estimated annual burden of between $1.4 billion and
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13.8 billion was attributed to community-acquired MRSA (CDC,
2013; Lee et al., 2013). Besides, MRSA has been established
as a pathogen for domestic animals and linked with livestock-
associated infections (Verkade and Kluytmans, 2013).
Methicillin resistance is usually due to the mecA gene, borne
on the staphylococcal cassette chromosome mec (SCCmec) that
codes for a 78-kDa penicillin binding protein (PBP2a), with
decreased aﬃnity to methicillin and all beta-lactam antibiotics
(Chambers, 1997). To date, eleven SCCmec types have been iden-
tiﬁed (IWG-SCC, 2009). Some cassettes, for example, SCCmec
II (53 kb) and SCCmec III (67 kb), are large and possess mobile
genetic elements (MGE), such as integrated plasmids (pUB110,
pI258, and pT181) and transposons (e.g., Tn554) (Ito et al., 2001),
and are frequently associated with hospital-acquired MRSA (Ma
et al., 2002; Ito et al., 2004). In contrast, SCCmec IV (21–24 kb)
and V (27 kb) are shorter elements, generally susceptible to
non-beta-lactam antibiotics, and linked with community MRSA
(Chambers and Deleo, 2010). However, the spread of various
MRSA clones between the hospital and community settings has
made the dichotomous ranking diﬃcult (Deurenberg and Sto-
bberingh, 2008). Recently, a variant mecA gene (named mecC)
which is situated on an SCCmec XI element has been described
(Shore et al., 2011). It has a higher relative aﬃnity for oxacillin as
compared with cefoxitin (Kim et al., 2012), and exhibits only 69%
sequence similarity at the nucleotide level and 63% amino-acid
identity to mecA/PBP2a (Paterson et al., 2014b). Furthermore,
based on whole genome sequencing, mutations of the endoge-
nous penicillin-binding proteins (PBP) 1, 2, and 3 in mecA and
mecC negative strains have been postulated as a possible alter-
native mechanism for beta-lactam resistance in MRSA (Ba et al.,
2014).
There is great interest in tracking, identifying and understand-
ing the diversity of MRSA in various settings. Currently, the most
widely used molecular techniques include Staphylococcus pro-
tein A gene typing (spa) and multilocus sequence typing (MLST).
Studies (particularly using MLST) have provided evidence that a
small set of lineages, clonal complex (CC)5, CC8, CC22, CC30,
and CC45, are associated with most of the MRSA infections in
hospitals (Stefani et al., 2012). Besides, a number of diﬀerent geo-
graphically distinct lineages, CC1, CC8, CC30, and CC80, have
also been associated with community MRSA infections (Chatter-
jee and Otto, 2013), while CC8 and CC30 have been identiﬁed
as pandemic lineages both in the hospital and community setting
(Chatterjee and Otto, 2013). Furthermore, regional clones have
been described in Australia (sequence type [ST] 93) (Coombs
et al., 2009), India (ST772) (D’Souza et al., 2010; Shambat et al.,
2012), South Korea (ST72) (Kim et al., 2007), Taiwan and China
(ST59) (Chen and Huang, 2014).
The distribution of MRSA clones in Africa is not well-
described. Understanding the molecular epidemiology of MRSA
in Africa is important as a recent review indicated that since
the year 2000, the prevalence of MRSA appears to be increas-
ing in many African countries and pose a visible threat to the
continent (Falagas et al., 2013). Furthermore, there is evidence
of the replacement of existing MRSA clones with diﬀerent and
new clonal types in a number of countries (Conceição et al.,
2007; Aires-de-Sousa et al., 2008; Albrecht et al., 2011; Espadinha
et al., 2013; Lim et al., 2013; Nimmo et al., 2013) but information
on this trend is lacking in Africa. The occurrence and changes
in clonal identities, and their geographic spread is important to
understand the spread and evolution of MRSA.
The Panton-Valentine Leukocidin (PVL) is a two-component
pore-forming toxin with cytolytic activity on deﬁned cells of
the immune system (neutrophils, macrophages and monocytes)
(Löﬄer et al., 2010; Yoong and Torres, 2013). It is encoded
by the lukS-PV and lukF-PV genes (Boakes et al., 2011), and
PVL-producing S. aureus exhibit a propensity for causing mainly
severe and often recurrent skin and soft tissue infections (Shall-
cross et al., 2013). In addition, PVL-positive MRSA are associated
with community onset-pneumonia (Vandenesch et al., 2003).
Although the PVL genes are mainly carried by community-
associated MRSA (CA-MRSA) (Vandenesch et al., 2003), data
fromWest and Central Africa showed that at least 40% of clinical
methicillin-susceptible S. aureus (MSSA) isolates in this region
are PVL-positive (Breurec et al., 2011a; Schaumburg et al., 2011;
Shittu et al., 2011; Egyir et al., 2014a). Therefore, the acquisi-
tion of the mecA gene by PVL-positive MSSA and the possible
dissemination of PVL-positive CA-MRSA could present a signif-
icant challenge in disease management and infection control in
resource-limited countries in Africa.
This systematic review examined published literature on the
molecular epidemiology of MRSA in Africa. By summarizing
currently available data on the continent, our objective was to
describe the distribution of MRSA clones, the prevalence of PVL-
positive MRSA, and to highlight the need to develop more com-
prehensive surveillance and reporting systems for multidrug-
resistant organisms such as MRSA in Africa.
Methods
This systematic review was conducted in accordance with
the preferred reporting items for systematic reviews and
meta-analyses (PRISMA) guidelines (Moher et al., 2009).
Literature Search Strategy
The relevant English and French articles available in ﬁve elec-
tronic databases (MEDLINE, EBSCOhost, ISI Web of knowl-
edge, Scopus, and African Journals Online) were retrieved by two
authors using predeﬁned search terms (Table S1). The literature
search was conducted until 31 October 2014.
Eligible Article Identification
Figure 1 summarizes the study selection process. All duplicate
articles were removed and data on MSSA as well as in-vitro stud-
ies were also excluded. The eligibility of published reports in
this review was based primarily on polymerase chain reaction
(PCR) detection of the mecA gene, and the use of at least one
molecular tool for genotyping ofMRSA strains (Table 1). In addi-
tion, worldwide surveys that covered African countries were also
included. An MRSA clone was deﬁned based on the combina-
tion of MLST sequence type (ST) and SCCmec typing data as
previously reported (Okuma et al., 2002). The nomenclature of
the SCCmec types was as proposed by the International Working
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FIGURE 1 | Preferred reporting item for systematic reviews. CONS, coagulase negative staphylococci; MSSA, methicillin susceptible S. aureus; MRSA,
methicillin resistant S. aureus.
Group on the Classiﬁcation of Staphylococcal Cassette Chromo-
some Elements (IWG-SCC, 2009). SCCmec elements that could
not be classiﬁed were indicated as non-typeable (SCCmec-NT).
In this study, we categorized MRSA into various CCs according
to the current eBURST scheme, Version 3 (accessed 30 October
2014) (eBURST, www.mlst.net, V3)1.
Data Extraction and Synthesis
The relevant data were extracted from each of the articles as
stated in Table 1. Separate articles that analyzed the same S.
aureus isolates but answered diﬀerent questions were considered
as a single study.
eBURST Analysis
The relationship between the MRSA STs described in this review
and other lineages reported world-wide was analyzed using the
eBURST scheme. The allelic proﬁles were downloaded from
the MLST website (http://saureus.mlst.net/) which included the
African MRSA STs as well as 223 representative and randomly
selected STs (from each CC) based on the diﬀerences in their
allelic proﬁles. The minimum spanning tree was constructed by
the goeBURST algorithm using the Phyloviz software v1.1 (http://
www.phyloviz.net/).
1eBURST [Online]. Available online at: http://www.mlst.net version 3.
Results
Literature Search
The systematic search of the ﬁve electronic databases yielded
1775 articles (Figure 1). No additional studies were identiﬁed
from AJOL. After the removal of duplicate studies and assess-
ment of titles and abstracts, 110 full-text articles were screened,
of which 57 studies were considered eligible for the qualitative
analysis according to our inclusion criteria.
Characteristics of the Studies Included in the
Systematic Review
Most of the data analyzed were obtained from single center stud-
ies conducted mainly in ﬁve countries; Tunisia (n = 13), Nigeria
(n = 9), South Africa (n = 7), Algeria (n = 5), and Egypt (n = 3)
(Table 1). Multicenter studies were only reported in two articles
(Goering et al., 2008; Breurec et al., 2011b), including a survey
which comprised ﬁve African countries, Cameroon, Madagas-
car, Morocco, Niger and Senegal (Breurec et al., 2011b), and
an inter-continental multicenter study, which included South
Africa (Goering et al., 2008). Only three studies investigated the
detection of MRSA in animals (Table 1).
In most of the reports included in this study, S. aureus was
identiﬁed by phenotypic and culture characteristics, while molec-
ular identiﬁcation (16S rRNA, detection of the thermonuclease
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and the elongation factor tu - nuc, tuf - genes) was performed
in only 12.3% (7/57). The screening for antibiotic resistance and
toxin/virulence genes were carried out in seven and 22 studies,
respectively (Table 1). Furthermore, all the eligible studies ana-
lyzed MRSA using at least one genotyping technique, and 59.6%
(34/57) provided adequate genotyping data on MRSA clones
from 15 African countries (Tables 1, 2). Studies included in this
systematic review did not investigate on themecC gene.
Community- and Hospital- Acquired MRSA
Overall, 51% (29/57) of the eligible studies provided the potential
source (hospital- or community-associated) of the MRSA strains.
Only 17.5% (10/57) reported MRSA from community settings
(Table 1). USA300 (ST8-IV [2B]) and other related sequence
types were noted both in health care and community settings in
nine African countries (Tables 1, 2). The “Brazilian/Hungarian
clone” (ST239-III [3A]) was associated with hospital-acquired
infections in nine countries (Tables 1, 2). Furthermore, the “West
Australia MRSA-2” (ST88-IV [2B]) was reported in community-
and hospital-acquired infections in several African countries
(Table 2).
Detection of Panton-Valentine Leukocidin (PVL)
Genes
The screening for PVL-associated genes (lukF-PV and lukS-PV)
was carried out in 44 studies, and the detection of PVL genes
was only reported in 32 studies (Table 1). In animals, PVL-
positive MRSA (ST5) was described in nasal samples of pigs from
Senegal (Fall et al., 2012). In humans, the proportion of PVL-
positive MRSA carriage and/or infections ranged from 0.3 to
100%. Studies from Algeria and Tunisia reported higher PVL
prevalence while investigations from South Africa reported the
lowest prevalence (Table 3). Overall, PVL-positive MRSA were
more frequently reported with skin and soft tissue infections, and
community-associated clones (Tables 1, 2). There was no report
on the role of PVL in necrotizing pneumonia caused by MRSA in
Africa.
MRSA Clones Reported in Africa Using the
Current eBURST Scheme
Figures 2, 3 summarize the MRSA clones identiﬁed in Africa
based on MLST CCs. By the current eBURST scheme, six main
CCs were identiﬁed: CC5, CC22, CC30, CC45, CC80, and CC88.
In addition, a number of diverse spa types were identiﬁed among
the MRSA clones in Africa (Table 2), but the distribution of spa
types t042 and t044 (associated with CC80-IV [2B]) appear to
be limited to three North African (Algeria, Egypt and Tunisia)
countries (Table 2).
Clonal Complex 5
This clonal complex is considered the largest group based on the
eBURST scheme (Figure 3). It was subdivided into three main
clusters and designated as CC5-ST1, ST5, and ST8.
MRSA CC5 with Sequence Type 1
This group was reported in Nigeria (Raji et al., 2013) and Tunisia
(Ben Jomàa-Jemili et al., 2013). The clonal type included the
PVL-positive ST1-V [5C] isolated from patients in a tertiary hos-
pital in Nigeria (Raji et al., 2013), and the PVL-negative ST1 with
a non-typeable SCCmec element (spa type t035 and agr type III)
identiﬁed in Tunisia (Ben Jomàa-Jemili et al., 2013). In addition,
an ST1 related sequence type (ST772-V [5C]), “the Bengal-Bay
clone” has been described in Nigeria (Raji et al., 2013).
MRSA CC5 with Sequence Type 5
This clone was documented in 14 studies and consisted of diverse
SCCmec elements (Table 2). The ST5-I [1B]/III [3A] were iden-
tiﬁed from clinical samples in health care institutions in South
Africa (Shittu et al., 2009; Moodley et al., 2010; Jansen van Rens-
burg et al., 2011; Oosthuysen et al., 2014). ST5-II [2A] has been
described in Nigeria (Raji et al., 2013), and Senegal (Breurec et al.,
2011b). ST5-IV [2B]-PVL-positive was the dominant clone in
hospitalized patients with skin and soft tissue infections in Dakar,
Senegal (Breurec et al., 2011b). In addition, ST5-IV [2B] was
detected from nasal samples of pigs in the same geographical area
(Fall et al., 2012). ST5-IV [2B] has also been identiﬁed in Alge-
ria (Ramdani-bouguessa et al., 2006), Gabon (Schaumburg et al.,
2011; Ateba Ngoa et al., 2012), Morocco (Breurec et al., 2011b),
and South Africa (Essa et al., 2009), while the SCCmec IVa
[2B] variant was recovered from hospitalized patients in Alge-
ria (Ramdani-bouguessa et al., 2006; Bekkhoucha et al., 2009),
Angola (Conceição et al., 2014), and São Tomé and Príncipe
(Conceição et al., 2013). Moreover, ST5-IVa [2B] was reported
from nasal samples of apparently healthy-hospital workers in
Angola (Conceição et al., 2014). Other ST5 and related clones
identiﬁed are ST5-V [5C] in Angola (Conceição et al., 2014),
Cameroon (Breurec et al., 2011b), and Nigeria (Shittu et al.,
2011), ST72-SCCmec-NT in South Africa (Jansen van Rensburg
et al., 2011), ST72-V [5C] in Angola and Ghana (Egyir et al.,
2013, 2014b; Conceição et al., 2014), and ST105-II [2A] from a
patient in São Tomé and Príncipe (Conceição et al., 2013). Fur-
thermore, ST650-IV [2B] was detected from clinical samples in
health care institutions in South Africa (Jansen van Rensburg
et al., 2011). Finally, ST2629-V [5C] was described in Angola
(Conceição et al., 2014).
MRSA CC5 with Sequence Type 8
MRSA assigned to this clone are widespread and diverse across
Africa as evidenced in 27 studies (Table 2). The ﬁrst known
early or ancestral clone, ST250-I [1B], was mainly associated
with hospital-acquired infections in Ibadan, South-West Nige-
ria (Ghebremedhin et al., 2009), and recently observed in Ghana
(Egyir et al., 2014b). ST8-II [2A] was only described in the
KwaZulu-Natal region of South Africa (Essa et al., 2009), while
a number of investigations reported ST8-IV [2B] in Angola
(Conceição et al., 2014), Cameroon (Breurec et al., 2011b),
Gabon (Schaumburg et al., 2011; Ateba Ngoa et al., 2012), Ghana
(Egyir et al., 2014b), Madagascar (Breurec et al., 2011b), Nige-
ria (Adesida et al., 2005; Shittu et al., 2012), São Tomé and
Príncipe (Conceição et al., 2013) and South Africa (Essa et al.,
2009). The MRSA isolates from Angola possessed the SCCmec
type IVd element (Conceição et al., 2014). ST612-IV [2B], a
double locus variant (dlv) of ST8-IV [2B], and only recently
reported as PVL-positive (Oosthuysen et al., 2014), is widespread
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TABLE 2 | Methicillin resistant Staphylococcus aureus clones reported in 34 eligible studies.
Country Clonal type ST-SCCmec Clonal complex spa type PVL status agr References
Algeria ST80-IV [2B] 80 ND + III Ramdani-bouguessa et al., 2006
ST37-IVa [2B] 30 ND + III
ST239-III [3A] 5 ND − I
ST239-IVa [2B] 5 ND − I
ST241-III [3A] 5 ND − I
ST637-III [3A] 5 ND − I
ST5-IV, IVa [2B] 5 ND +, − II
ST635-IV [2B] 80 ND − III
ST636-NT 22 ND − I
ST80-IV [2B] 80 t044 + ND Bekkhoucha et al., 2009
ST239-III [3A] 5 t037 − ND
ST5-IVa [2B] 5 t311, t450 − ND
ST88-NT 88 t188, t267 − ND
ST80-IV [2B] 80 t044, t4143 + III Antri et al., 2011
ST241-III [3A] 5 ND − III
ST8-V [5C] 5 ND − I
ST80-IVc [2B] 80 ND +, − ND Djoudi et al., 2013
ST39-II [2A] 30 ND − ND
Angola ST5-IVa [2B] 5 t105, t311, t11657 − II Conceição et al., 2014
ST8-IVd, V [2B] 5 t104, t1774 − I
ST72-V [5C] 5 t3092 − I
ST88-IVa [2B] 88 t186, t325, t786, − III
t1951, t3869
ST5-V [5C] 5 t6065 − II
ST2629-V [5C] 5 t6065 − II
ST789-V [5C] 7 t091 − II
Cameroon ST5-V [5C] 5 t311 + II Breurec et al., 2011b
ST88-IV [2B] 88 t186 − III
ST8-IV [2B] 5 t024, t121, t451 + I
ST1289-V [5C] 88 t1339 + III
Egypt ST80-IVc [2B] 80 t042, t044, t070, t983 + III Enany et al., 2010
ST30-IVa [2B] 30 t251, t318 + III
ST1010-Xa 121 t159, t312 + IV
Gabon ST8-IV [2B] 5 t121 + I Schaumburg et al., 2011; Ateba
Ngoa et al., 2012ST88-IV [2B] 88 t186 − III
ST5-IV [2B] 5 t653 − II
ST5-IV [2B] 5 t653 − ND Schaumburg et al., 2014
ST8-NT 5 t112, t121 + ND
ST45-V [5C] 45 t437, t8860 − ND
ST88-IV [2B] 88 t4195 − ND
Ghana ST72-V [5C] 5 t537 − ND Egyir et al., 2013
ST8-V [5C] 5 t064 − ND
ST88-IV [2B] 88 t325, t1951, t2649 − ND
ST72-V [5C] 5 t537 − ND Egyir et al., 2014b
ST8-IV [2B] 5 t121 + ND
ST239-III [3A] 5 t037 − ND
ST250-I [1B] 5 t928 − ND
ST2021-V [5C] 5 t024 − ND
(Continued)
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TABLE 2 | Continued
Country Clonal type ST-SCCmec Clonal complex spa type PVL status agr References
ST88-IV [2B] 88 t186 − ND
ST789-IV [2B] 7 t547 + ND
ST508-V [5C] 45 t5132 − ND Egyir et al., 2014a
Kenya ST239-III [3A] 5 t037 − ND Aiken et al., 2014
Madagascar ST8-IV [2B] 5 t121 + I Breurec et al., 2011b
ST30-V [5C] 30 t4686 − III
ST88-IV [2B] 88 t186 − III
Morocco ST239, ST241-III [3A] 5 t037, t138 − I
ST5-IV [2B] 5 t311 + II
Niger ST239, ST241-III [3A] 5 t138 − I
ST239, ST241-V [5C] 5 t037 − I
ST88-IV [2B] 88 t186 − III
Nigeria ST8-IV [2B] 5 ND − ND Adesida et al., 2005
ST88-IV [2B] 88 t186 + III Ghebremedhin et al., 2009
ST241-IV [2B] 5 t037 − I
ST250-I [1B] 5 t194, t292 − I
ST241-III [3A] 5 t037 − ND Shittu et al., 2011
ST8-V [5C] 5 t064 − ND
ST8-V [5C] 5 t451 − ND
ST94-IV [2B] 5 t008 − ND
ST5-V [5C] 5 t002 − ND
ST241-III [3A] 5 t037 − ND Shittu et al., 2012
ST88-IV [2B] 88 t729, t1603 − ND
ST37-III [3A] 30 t074 − ND
ST39-II [2A] 30 t007 − ND
ST8-V [5C],IV [2B], ST8-NT 5 t064 − ND
ST152-NT 152 t4690 + ND
ST1-V [5C] 5 ND + ND Raji et al., 2013
ST239-III[3A]mercury 5 ND − ND
ST5-II [2A] 5 ND − ND
ST8-V [5C] 5 ND − ND
ST247-I [1B] 5 ND − ND
ST772-V [5C] 5 ND + ND
ST88-IV [2B] 88 ND − ND
ST241-III [3A] 5 ND − ND Okon et al., 2009
Senegal ST5-IV [2B]* 5 t311 + ND Fall et al., 2012
ST88-IV [2B]* 88 t3489 − ND
ST239, ST241-III [3A] 5 t037, t138 − I Breurec et al., 2011b
ST5-II [2A] 5 t311 + II
ST5-IV [2B] 5 t311 + II
ST88-IV [2B] 88 t168 − III
South Africa ST5-IV [2B] 5 ND ND ND Essa et al., 2009
ST8-IV [2B] 5 ND ND ND
ST8-II [2A] 5 ND ND ND
(Continued)
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TABLE 2 | Continued
Country Clonal type ST-SCCmec Clonal complex spa type PVL status agr References
ST239-III [3A] 5 ND ND ND
ST45-IV [2B] 45 ND ND ND
ST612-IV [2B] 5 ND − ND Goering et al., 2008
ST36-II [2A] 30 ND − ND
ST1173-IV [2B] 5 t064 − ND Shittu et al., 2009
ST1338-IV [2B] 5 t064 − ND
ST239-III [3A] 5 t037 − ND
ST5-III [3A] 5 t045 − ND
ST239-III [3A] 5 t037 − ND Moodley et al., 2010
ST612-IV [2B] 5 t064 − ND
ST5-I [1B] 5 t045 − ND
ST22-IV [2B] 22 t032 − ND
ST22-IV [2B] 22 t891 + ND
ST36-II [2A] 30 t012 − ND
ST239-III [3A] 5 t037 − ND Jansen van Rensburg et al., 2011
ST5-I [1B] 5 t045 ND ND
ST650-IV [2B] 5 t002 ND ND
ST612-IV [2B] 5 t064, t1443, t2196 ND ND
ST72-NT 5 t3092 ND ND
ST22-IV [2B] 22 t032 ND ND
ST36-II [2A] 30 t012, t021 ND ND
ST5-I [1B] 5 t002 − II Oosthuysen et al., 2014
ST8-V [5C] 5 t064 − I
ST612-IV [2B] 5 t064 + I
ST239-III [3A] 5 t021 − I
ST22-V [5C] 22 t891 + I
ST22-IV [2B] 22 t891 − I
ST36-II [2A] 30 t021 − III
São Tome ST5-IVa [2B] 5 t105 − II Conceição et al., 2013
and Príncipe ST105-II [2A] 5 t002 − II
ST8-V [5C] 5 t451 − I
ST8-IV [2B] 5 t451 − I
ST88-IVa [2B] 88 t186, t786 − III
Tunisia ST80-IV [2B] 80 t044 + III Ben Nejma et al., 2009
ST80-IV [2B] 80 t044 + III Ben Nejma et al., 2013
ST728-IVc [2B] 80 t042, t044 + III Kechrid et al., 2011
ST8-IVc [2B] 5 t062 + II
ST80-IVc [2B] 80 t203 + III Ben Slama et al., 2011
ST1-NT 5 t035 − III Ben Jomàa-Jemili et al., 2013
ST247-I [1B] 5 t040 − I
ST239-III [3A] 5 t003 − I
ST241-III [3A] 5 t125 − I
ST97-NT 5 t003 − I
ST1819-I [1B] 5 NS − I
ST80-IVc [2B] 80 t070 + III
ST2563-IVc [2B] 80 t070 + III
(Continued)
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TABLE 2 | Continued
Country Clonal type ST-SCCmec Clonal complex spa type PVL status agr References
ST1440-IVc [2B] 80 t070 + III
ST80-IVc [2B] 80 t1021 − II
ST80-IVc [2B] 80 ND − III
ST22-NT 22 t998 − II
ST45-NT 45 ND − I
ST153-NT 80 NST + III
ST153-NT 80 t044 ND III Gharsa et al., 2012
agr, Accessory gene regulator; CC, Clonal complex; NT, Non typeable; ND, Not determined; NST, New spa type; PVL, Panton-Valentine Leukocidin genes; SCCmec, Staphylococcal
chromosomal cassette mec element; ST, Sequence type; spa, Staphylococcus aureus protein A gene; Xa, Unknown SCCmec type other than I, II, III, IV or V; *Clones isolated from pigs;
+, PVL positive; −, PVL negative.
TABLE 3 | Panton-Valentine Leukocidin prevalence as reported by the
eligible studies with sample size of 30 or above.





Algeria 46/61 75 Ramdani-bouguessa et al.,
2006
19/64 30 Ouchenane et al., 2011
94/122 77 Antri et al., 2011
Kenya 14/69 20 Maina et al., 2013
Libya 10/35 29 Al-haddad et al., 2014
Nigeria 33/70 47 Ghebremedhin et al., 2009
South Africa 1/320 0.3 Moodley et al., 2010
4/97 4 Makgotlho et al., 2009
5/56 9 Oosthuysen et al., 2014
Tunisia 68/72 94 Ben Nejma et al., 2006
64/64 100 Ben Nejma et al., 2013
43/69 62 Ben Jomàa-Jemili et al.,
2013
Uganda 30/41 73 Kateete et al., 2011
Multicenter* 20/86 23 Breurec et al., 2011b
*Multicenter study which included Cameroon, Madagascar, Morocco, Niger and Senegal.
PVL, Panton-Valentine Leukocidin; no., Number.
across South Africa (Goering et al., 2008; Moodley et al., 2010;
Jansen van Rensburg et al., 2011; Oosthuysen et al., 2014),
alongside other variants such as ST1173/ST1338-IV [2B] (Shittu
et al., 2009). The ST8-IV [2B] clone in South Africa was iden-
tiﬁed from a variety of clinical infections, in particular, bacter-
aemia, skin and soft tissue and wound infections (Shittu et al.,
2009; Moodley et al., 2010; Jansen van Rensburg et al., 2011;
Oosthuysen et al., 2014). An ST8-IVc [2B] strain (PVL-positive;
spa type t062) was identiﬁed from a 4 day old male child with
community-acquired invasive infection in Tunisia (Kechrid et al.,
2011). Furthermore, ST8-V [5C] was described in Algeria (Antri
FIGURE 2 | MRSA clones reported in Africa. Each clonal complex is
annotated with a colored circle. The number of studies conducted in each
country is also indicated.
et al., 2011), Angola (Conceição et al., 2014), Ghana (Egyir et al.,
2013), Nigeria (Shittu et al., 2011, 2012; Raji et al., 2013), São
Tomé and Príncipe (Conceição et al., 2013), and South Africa
(Oosthuysen et al., 2014). Other STs observed within the CC5-
ST8 cluster include ST8-SCCmec-NT in Gabon (Schaumburg
et al., 2014) and Nigeria (Shittu et al., 2012), ST94-IV [2B]
described in Nigeria (Shittu et al., 2011) and ST97-SCCmec-NT
in Tunisia (Ben Jomàa-Jemili et al., 2013). In addition, ST247-I
[1B] was reported only in Tunisia (Ben Jomàa-Jemili et al., 2013)
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FIGURE 3 | The minimum spanning tree was constructed by the
goeBURST algorithm using the Phyloviz software v1.1
(http://www.phyloviz.net/). The allelic profiles were downloaded from
the MLST website (http://saureus.mlst.net/) which included the MRSA
sequence types (STs) described in this review as well as 223
randomly selected STs (from each CC) based on the differences in
their allelic profiles. The Group founder is colored in green and the
related STs are in blue. The six main CCs described in this review
are indicated by the dotted lines and the STs reported in Africa are
indicated by the red color.
and Nigeria (Raji et al., 2013), ST637-III [3A] in Algeria
(Ramdani-bouguessa et al., 2006), ST1819-I [1B] in Tunisia
(Ben Jomàa-Jemili et al., 2013), and ST2021-V [5C] in Ghana
(Egyir et al., 2014b).
The “Brazilian/Hungarian clone” (ST239-III [3A]) is an
hybrid of CC30 and CC8 based on a single large chromoso-
mal replacement (Robinson and Enright, 2004), and ST241-III
[3A] is a single locus variant (slv) of ST239-III [3A]. These two
STs were identiﬁed concurrently in Algeria (Ramdani-bouguessa
et al., 2006), Morocco, Niger and Senegal (Breurec et al., 2011b),
and Tunisia (Ben Jomàa-Jemili et al., 2013). ST239-III [3A] has
also been described in Ghana (Egyir et al., 2014b) and Kenya
(Aiken et al., 2014), and consistently since 2001 in South Africa
(Essa et al., 2009; Shittu et al., 2009; Moodley et al., 2010; Jansen
van Rensburg et al., 2011; Oosthuysen et al., 2014). A recent study
detected ST239 with the SCCmec type IIImercury [3A] in a ter-
tiary health care facility in South-West Nigeria (Raji et al., 2013).
ST241-III [3A] is the dominant clone in North-East Nigeria
(Okon et al., 2009; Shittu et al., 2011, 2012). Interestingly, three
SCCmec variants, ST239-IVa [2B], ST239/ST241-V [5C], and
ST241-IV [2B], and associated with hospital-acquired infec-
tions were reported in Algeria (Ramdani-bouguessa et al., 2006),
Niger (Breurec et al., 2011b), and Nigeria (Ghebremedhin et al.,
2009).
Clonal Complex 22
In Africa, ST22 was identiﬁed only in Algeria (Ramdani-
bouguessa et al., 2006), South Africa (Moodley et al., 2010;
Jansen van Rensburg et al., 2011; Oosthuysen et al., 2014), and
Tunisia (Ben Jomàa-Jemili et al., 2013). ST22-IV [2B] was related
with hospital-associated infections in the Western Cape and
KwaZulu-Natal provinces of South Africa. A variant of ST22
(ST22-V [5C]-PVL-positive) was also reported in an hospital in
Western Cape, South Africa (Oosthuysen et al., 2014). The ST22
identiﬁed in Tunisia possessed a non-typeable SCCmec element
(Ben Jomàa-Jemili et al., 2013). Besides, an ST636-SCCmec-NT
isolate has also been reported in Algeria (Ramdani-bouguessa
et al., 2006).
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Clonal Complex 30
ST30-IVa [2B]-PVL-positive, also known as “South-West Paciﬁc
clone,” has been reported in Egypt (Enany et al., 2010), and
a multicenter African study identiﬁed ST30-V [5C] only in
Antananarivo, Madagascar (Breurec et al., 2011b). The hospital
associated ST36-II [2A] (UK-EMRSA-16), was described only in
South Africa (Goering et al., 2008; Moodley et al., 2010; Jansen
van Rensburg et al., 2011; Oosthuysen et al., 2014), while ST39-
II [2A] a dlv was identiﬁed in an hospital in Algiers, Algeria
(Djoudi et al., 2013), and Ile-Ife, South-West Nigeria (Shittu
et al., 2012). MRSA assigned with these groups (ST36-II [2A] and
ST39-II [2A]) were PVL-negative. Furthermore, two SCCmec
variants, ST37-IVa [2B] and ST37-III [3A], were reported in
Algeria (Ramdani-bouguessa et al., 2006) and Nigeria (Shittu
et al., 2012), respectively.
Clonal Complex 45
ST45-IV [2B], the “Berlin clone,” was detected in an hospi-
tal in the KwaZulu-Natal (South Africa) during a multicen-
ter surveillance study (Essa et al., 2009) and ST45-V [5C] was
reported in mother-infant pairs in Gabon (Schaumburg et al.,
2014). An MRSA with a non-typeable SCCmec associated with
community-acquired infections has been identiﬁed in Tunisia
(Ben Jomàa-Jemili et al., 2013). Finally, ST508-V [5C], a slv to
ST45, and also associated with community-acquired infections
was described in Ghana (Egyir et al., 2014a).
Clonal Complex 80
The CC80 was limited to three North African countries: Alge-
ria, Egypt, and Tunisia (Table 2). The European clone, ST80-IV
[2B]-PVL-positive, was ﬁrst described in Algeria from both hos-
pitalized and outpatients (Ramdani-bouguessa et al., 2006), and
has continued to be the leading clone in the country (Ramdani-
bouguessa et al., 2006; Bekkhoucha et al., 2009; Antri et al.,
2011; Djoudi et al., 2013). ST80-IVc [2B] has been identiﬁed
in Egypt (Enany et al., 2010), and Tunisia (Ben Slama et al.,
2011; Ben Jomàa-Jemili et al., 2013). In addition, sequence types
related to ST80 have been recovered from human clinical sam-
ples (ST153-SCCmec-NT, ST728-IVc [2B], ST1440-IVc [2B], and
ST2563-IVc [2B]) (Kechrid et al., 2011; Ben Jomàa-Jemili et al.,
2013), and nasal specimen of healthy sheep (ST153-SCCmec-NT)
(Gharsa et al., 2012) in Tunisia. The afore-mentioned sequence
types, ST728, ST1440 and ST2563 belonged to accessory gene
regulator (agr) type III and were PVL-positive. Moreover, a
PVL-negative ST80-IVc [2B] with agr type II has also been
detected in Tunisia (Ben Jomàa-Jemili et al., 2013), and a PVL-
negative ST635-IV [2B] in Algeria (Ramdani-bouguessa et al.,
2006).
Clonal Complex 88
The “West Australia MRSA-2 clone” (WA-MRSA-2), ST88-IV
[2B], was reported in both hospital and community settings
in eight African countries; Angola (Conceição et al., 2014),
Cameroon (Breurec et al., 2011b), Gabon (Schaumburg et al.,
2011; Ateba Ngoa et al., 2012), Ghana (Egyir et al., 2013, 2014b),
Madagascar (Breurec et al., 2011b), Niger (Breurec et al., 2011b),
Nigeria (Ghebremedhin et al., 2009; Shittu et al., 2012; Raji et al.,
2013) and Senegal (Breurec et al., 2011b). The MRSA isolates
from Angola possessed an SCCmec IVa [2B] element (Conceição
et al., 2014). PVL-positive ST88-IV [2B] were detected in Nigeria
(Ghebremedhin et al., 2009), and an SCCmec subtype ST88-IVa
[2B] was identiﬁed among three health care workers and a patient
in São Tomé and Príncipe (Conceição et al., 2013). The ST88-IV
[2B] with spa type t3489 was also recovered from nasal samples
of swine in Senegal (Fall et al., 2012). In addition, an SCCmec
non-typeable ST88 was described from an out-patient in Algeria
(Bekkhoucha et al., 2009), and a strain related to WA-MRSA-2
(ST1289-IV [2B]) was identiﬁed in Yaoundé, Cameroon (Breurec
et al., 2011b).
Other Clonal Complexes
CC7, CC121, and CC152 have been reported in Africa. The PVL-
negative ST789 (assigned with CC7) was identiﬁed in Angola
(with SCCmec IV [2B]) (Conceição et al., 2014). However, in
Ghana, ST789 was PVL-positive and carried an SCCmec IV
element [2B] (Egyir et al., 2014b). An ST1010-PVL-positive
(CC121) with non-typeable SCCmec element has only been
described in Egypt (Enany et al., 2010). Furthermore, PVL-
positive MRSA assigned to CC152 (ST152-SCCmec-NT) was
reported in Nigeria (Shittu et al., 2012).
Discussion
MRSA has been reported in Africa, at least since 1978 (Scragg
et al., 1978). This systematic review showed that adequate data on
the molecular epidemiology of MRSA are limited, with reports
from only 15 of the 54 African countries. No spa type was
dominant, however, t042 and t044 were the major spa types
identiﬁed in three North African countries (Table 2). Moreover,
we did not observe a clear distinction between hospital- and
community-associated MRSA clones in Africa which is in agree-
ment with other investigations worldwide (Fossum Moen et al.,
2013; Pasquale et al., 2013; Sherwood et al., 2013; Tavares et al.,
2013). In this systematic review, the use of the current eBURST
scheme grouped several African MRSA CCs (CC1, CC5, CC8,
and CC7) into a single cluster, (CC5). This raises some con-
cern on a suitable method for discrimination and grouping of S.
aureus isolates. To overcome the above mentioned issue, whole
genome sequencing approach might be the alternative (Dabul
and Camargo, 2014).
Although a combination of factors could be responsible for
the dissemination of clones between continents, increased move-
ment of human population within or between countries might
be one of the potential factors (Rogers et al., 2011). International
travel could play a signiﬁcant role in the transmission of MRSA,
particularly the replacement of existing MRSA with ﬁtter and
more transmissible clones (Zhou et al., 2014). We observed that
the predominant hospital-associated epidemic clones, EMRSA-
15 [ST22-IV [2B]) and (EMRSA-16 [ST36-II [2A]), in the United
Kingdom (UK) (Johnson et al., 2005) were reported only in South
Africa (Goering et al., 2008; Moodley et al., 2010; Jansen van
Rensburg et al., 2011; Oosthuysen et al., 2014). Moreover, ST80-
IV [2B] (the European clone) has consistently been recognized
as the predominant PVL-positive MRSA clone in North Africa
Frontiers in Microbiology | www.frontiersin.org 15 April 2015 | Volume 6 | Article 348
Abdulgader et al. A systematic review on MRSA in Africa
(Ramdani-bouguessa et al., 2006; Bekkhoucha et al., 2009; Ben
Nejma et al., 2009, 2013; Enany et al., 2010; Antri et al., 2011;
Ben Slama et al., 2011; Ben Jomàa-Jemili et al., 2013; Djoudi
et al., 2013). A recent report based on whole genome analy-
sis provided strong evidence that the European ST80-IV [2B]
was derived from a PVL-positive MSSA ancestor in sub-Saharan
Africa that acquired the SCCmec IV element, and clonal spread
was enhanced by increased transnational movement (Stegger
et al, 2014). However, the factors responsible for the limited
spread of the ST80-IV [2B] only in North Africa observed so far
are unclear.
The SCCmec IV (and its subtypes) and SCCmec V were iden-
tiﬁed in several MRSA clones, and ST5 and ST8 clearly showed
more diversity in terms of SCCmec types compared with other
STs in Africa. The success of these SCCmec types (IV and V)
could be due to their small sizes and low ﬁtness costs (Enright
et al., 2002; Okuma et al., 2002; Monecke et al., 2011). It is
also noteworthy that the SCCmec types IVa and IVc were iden-
tiﬁed in genetically unrelated clones, e.g., ST5-IVa [2B] (CC5)
in Algeria (Ramdani-bouguessa et al., 2006; Bekkhoucha et al.,
2009), São Tomé and Príncipe (Conceição et al., 2013), ST8-
IVc [2B] in Tunisia (CC5) (Kechrid et al., 2011), and ST37-IVa
[2B] (CC30) in Algeria (Ramdani-bouguessa et al., 2006). This
might suggest horizontal gene transfer or independent acquisi-
tion (Mašlaòová et al., 2013). Another interesting observation
was the detection of the SCCmec type IVa and V in the hospital-
associated ST239/ST241-III [3A] in Algeria (Ramdani-bouguessa
et al., 2006), Nigeria (Ghebremedhin et al., 2009), and Niger
(Breurec et al., 2011b). Since ancient MSSA strains for this ST
have not been reported (Enright et al., 2002), our observation
suggests that acquisition of these SCCmec types by MSSA is less
likely, and points to the possible replacement of SCCmec type III
with IV and V on the ST239/241 genome (Li et al., 2013).
Data on the epidemiology of MRSA in animals are limited
in Africa (EL Seedy et al., 2012; Fall et al., 2012; Gharsa et al.,
2012). Moreover, the genetic relatedness between human and
animal MRSA has not been investigated (Table 2). It should be
noted, however, that human-associated ST5-IV [2B], ST88-IV
[2B], and ST153-SCCmec-NT have been reported from animals
in Tunisia (Gharsa et al., 2012) and Senegal (Fall et al., 2012).
Recently, human-associated S. aureus lineages were described
in captive Chimpanzees in Gabon, Madagascar, Uganda and
Zambia (Schaumburg et al., 2012, 2013; Nagel et al., 2013).
Notably, a likely case of S. aureus transmission from a veterinar-
ian to a chimpanzee from the same sanctuary was demonstrated
(Schaumburg et al., 2012). Zoonotic transmission may consti-
tute a major concern in Africa, where there is often substan-
tial exposure to domesticated animals (Fall et al., 2012; Gharsa
et al., 2012). Furthermore, animal-adapted clones might undergo
further host-adaptive evolutionary changes, which could result
in an epidemic spread of new and more virulent strains in the
human population (Spoor et al., 2013). Other risk factors for
animal to human MRSA transmission, which include contam-
inated environment (Verkade and Kluytmans, 2013) and meat
products (Hamid and Youssef, 2013), have not been investi-
gated in Africa. Livestock-associated MRSA are widespread in
Europe, but the transmission of these strains to humans is
either rare or limited to people with direct contact with MRSA
infected/carrier animals (Verkade and Kluytmans, 2013). Using
whole genome sequencing, evidence of zoonotic transmission
of MRSA harboring mecC was reported in Denmark (Harri-
son et al., 2013). The mecC-positive MRSA, initially known as
a livestock MRSA belonging to the CC130, is recognized in
both animals and humans in Europe (Paterson et al., 2014a). In
addition, this clone has been implicated in severe infections in
humans (Paterson et al., 2014b), resulting in one death (García-
Garrote et al., 2014). The clinical importance of mecC-positive
MRSA is not yet clear in Africa as data is unavailable. Therefore,
we suggest that surveillance for MRSA should include detec-
tion of the mecC gene where mecA is not detected in resistant
isolates.
This systematic review did not seek to provide comprehen-
sive information on the burden of PVL-positive MRSA in Africa.
However, it provided some interesting observations on their epi-
demiology in Africa such as the identiﬁcation of PVL-positive
isolates assigned with CC7 (originally classiﬁed with CC152)
in Ghana (Egyir et al., 2014a), CC88-IV [2B] in Cameroon
(Breurec et al., 2011b) and Nigeria (Ghebremedhin et al., 2009),
ST612-IV [2B] in South Africa (Oosthuysen et al., 2014), and
CC152 in Nigeria (Shittu et al., 2012). Until now, CC152 was
only described in the Balkan region (Francois et al., 2008).
The mode of acquisition of the mecA gene by ST152 is still
unknown, but it might be explained by either its introduction
through international travel or the acquisition of the methi-
cillin resistance gene by PVL-positive MSSA, which is prevalent
in West and Central Africa (Ruimy et al., 2008; Okon et al.,
2009; Breurec et al., 2011a; Schaumburg et al., 2011; Shittu et al.,
2011, 2012; Egyir et al., 2014a). These observations highlight
the need for further surveillance data (including information on
community-acquired necrotizing pneumonia) to understand the
epidemiology of PVL-associated S. aureus in both hospital and
community settings on the African continent.
Conclusion
A number of pandemic MRSA clones were identiﬁed in Africa.
In contrast, some MRSA clones are limited to speciﬁc countries
or regions. Although the eBURST snapshot provided a descrip-
tion of the relationship between the MRSA clones reported in
Africa and other lineages submitted into the MLST database
from other continents, the objective of this review was not to
understand the origin of MRSA clones in Africa, as this will
require in depth analysis like whole genome sequencing. How-
ever, it did show that CC5 is the largest group and predominant
in Africa. Nevertheless, the limited data available on MRSA in
Africa draw attention to the need for increased surveillance of
MRSA and molecular epidemiological studies. We strongly rec-
ommend improved co-operation between clinicians and micro-
biologists in Africa. This synergy could provide an understanding
on the local epidemiology of MRSA. In addition, we strongly
advocate the establishment of eﬀective diagnostic microbiology
facilities that will incorporate high-throughput technologies for
monitoring the clonal expansion and dissemination of MRSA. In
the meantime, increased networking through collaboration with
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S. aureus reference centers could provide support for genotyp-
ing services to African countries with limited resources. Finally,
population-based surveillances for MRSA are needed to evaluate
the situation of community associatedMRSA as well as studies on
MRSA from animal hosts. To understand the origin of the newly
emerged clones, MSSA genotyping needs to be incorporated with
MRSA surveillance studies.
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